Goldman Sachs Starts Amgen (AMGN) at Buy

December 6, 2021 6:17 AM EST Send to a Friend
Goldman Sachs analyst Salveen Richter initiates coverage on Amgen (NASDAQ: AMGN) with a Buy rating and a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login